Verseau Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 21, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Traction
- Our data suggests that we can at least double the patient population benefitting from immunotherapy.
- Company Description
- Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
- Market
- Cancer therapeutics and immune/inflammatory diseases
- Location
- Bedford, MA, USA
- Coinvestors
- 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners, The Mark Foundation for Cancer Research, Yonghua Capital